Treatment of fibrosis using FXR ligands

Details for Australian Patent Application No. 2005222994 (hide)

International Classifications

Event Publications

19 October 2006 PCT application entered the National Phase

PCT publication WO2005/089316 Priority application(s): WO2005/089316

1 September 2011 Application Accepted

Published as AU-B-2005222994

6 October 2011 Application for Amendment

The nature of the amendment is as shown in the statement(s) filed 09 Sep 2011. Address for service in Australia - Spruson & Ferguson Level 35 St Martins Tower 31 Market Street Sydney NSW 2000

2 February 2012 Amendment Made

The nature of the amendment is as shown in the statement(s) filed 09 Sep 2011

2 February 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.